Alamar生物科学公司启动了血液测试,测量了5个阿尔茨海默氏生物标志,以供研究使用。 Alamar Biosciences launches a blood test measuring five Alzheimer’s biomarkers for research use.

Alamar生物科学公司引入了NULISAqpcrTM AD 5-Plex Asssay,这是一个只进行研究的测试,从单一样本中测量了5个阿尔茨海默氏血缘标——BD-pTau217、NfL、Aβ42、GFAP和APOE4状况。 Alamar Biosciences has introduced the NULISAqpcr™ AD 5-plex Assay, a research-only test that measures five Alzheimer’s-related blood biomarkers—BD-pTau217, NfL, Aβ42, GFAP, and APOE4 status—from a single sample. 该分析旨在用于研究,通过分析神经退化的关键指标,支持早期发现和监测阿尔茨海默氏症。 The assay, designed for use in research, supports early detection and monitoring of Alzheimer’s by analyzing key indicators of neurodegeneration. 它符合阿尔茨海默氏协会的指导方针,并利用精确蛋白质组学改进对疾病风险和进展的非侵入性评估。 It aligns with Alzheimer’s Association guidelines and leverages precision proteomics to improve non-invasive assessment of disease risk and progression.